ADIA to Invest USD 200 Million in Meril
Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics.
Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100-acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation.
With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually.
Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
19 minutes ago
- News18
General Motors profit, revenue drops, but it maintains lowered full year outlook
Agency: PTI Last Updated: Detroit, Jul 22 (AP) General Motors' profit and revenue declined in its second-quarter but the automaker easily topped expectations and the company stuck by its full-year financial outlook that it lowered in May. GM CEO Mary Barra also said in a letter to shareholders on Tuesday that the automaker is attempting to 'greatly reduce our tariff exposure", citing USD 4 billion of new investment in its US assembly plants. 'In addition to our strong underlying operating performance, we are positioning the business for a profitable, long-term future as we adapt to new trade and tax policies, and a rapidly evolving tech landscape," she said. For the three months ended June 30, GM earned USD 1.89 billion, or USD 1.91 per share. A year earlier the company earned USD 2.93 billion, or USD 2.55 per share. Stripping out certain items, earnings were USD 2.53 per share. That handily beat the USD 2.34 per share analysts polled by FactSet were calling for. Shares still declined 3 per cent before the opening bell Tuesday. Barra remains optimistic about the electric vehicle market. 'Despite slower EV industry growth, we believe the long-term future is profitable electric vehicle production, and this continues to be our north star," she wrote. 'As we adjust to changing demand, we will prioritize our customers, brands, and a flexible manufacturing footprint, and leverage our domestic battery investments and other profit-improvement plans." The company maintained its full-year financial forecast. In May General Motors lowered its profit expectations for the year as the carmaker braced for a potential impact from auto tariffs as high as USD 5 billion in 2025. The Detroit automaker said at the time that it anticipated full-year adjusted earnings before interest and taxes in a range of USD 10 billion to USD 12.5 billion. The guidance includes a current tariff exposure of USD 4 billion to USD 5 billion. A month later GM announced plans to invest USD 4 billion to shift some production from Mexico to US manufacturing plants. The company said at the time that the investment would be made over the next two years and was for its gas and electric vehicles. President Donald Trump signed executive orders in April to relax some of his 25 per cent tariffs on automobiles and auto parts, a significant reversal as the import taxes threatened to hurt domestic manufacturers. Automakers and independent analyses have indicated that the tariffs could raise prices, reduce sales and make US production less competitive worldwide. Trump portrayed the changes as a bridge toward automakers moving more production into the United States. The tariffs ordered by Trump are hitting the entire auto sector, which sends vehicles and parts across the northern and southern borders of the US repeatedly as they are assembled. The Centre for Automative Research says that a uniform 25 per cent tariff on all trading partners would have an increased cost of USD 107.7 billion to all US automakers and an increased cost of USD 41.9 billion for the Big Three automakers in Detroit, Stellantis, GM and Ford. GM reported its financial results a day after Jeep maker Stellantis said that its preliminary estimates show a 2.3 billion euros (USD 2.68 billion) net loss in the first half of the year due to US tariffs and some hefty charges. Stellantis will release its financial results for the first half of the year on July 29. (AP) SKS SCY SCY view comments First Published: July 22, 2025, 19:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
19 minutes ago
- News18
Escape Plan raises Rs 45 cr seed funding from investors
Agency: PTI New Delhi, Jul 22 (PTI) Escape Plan, a Bengaluru-based lifestyle startup, has raised USD 5 million (about Rs 45 crore) in seed funding led by clutch of investors including Jungle Ventures and Fireside Ventures. The funding will be utilised to expand the company's retail footprint, accelerate customer acquisition, and strengthen its quick-commerce integrations, Escape Plan said in a statement. Over the next 18-24 months, Escape Plan plans to launch over 100 offline stores across India, it said. The company also plans to integrate with quick-commerce and travel discovery platforms to offer 1-hour delivery in key markets, addressing the growing need for last-minute travel solutions and gifting. 'Our aim is to build a platform that offers curated, functional, and design-forward products for this rapidly growing consumer base and elevate the experience of people while travelling," said Escape Plan founder & CEO Abhinav Pathak. Escape Plan offers a curated multi-brand ecosystem of travel gear — including luggage, duffels, backpacks, slings, pouches, and modular accessories — combining style, function, and accessibility. PTI DP HVA Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
an hour ago
- Time of India
From charity to capitalism with conscience, ESG gains ground in Indian healthcare and pharma
New Delhi: As India's healthcare sector races toward a projected USD 596 billion valuation by 2025, a quiet but powerful shift is underway—Environmental, Social, and Governance (ESG) principles are emerging as the next big disruptor. No longer just a corporate buzzword, ESG is now being seen as a critical framework to tackle inequities, attract impact-driven capital , and build a resilient, inclusive healthcare ecosystem. Experts say ESG could be the game-changer India needs to move beyond piecemeal CSR initiatives and government subsidies—offering instead a data-backed, accountability-driven approach to bridging access gaps, especially in rural and underserved regions. Despite its massive scale, healthcare accounts for just six per cent of the total market capitalisation of the top 1,000 NSE-listed firms—highlighting an urgent need for long-term, value-based transformation. With over 7.5 million workers across hospitals, pharmaceuticals, diagnostics, medtech, and biotech, embedding ESG may not just boost investor trust—it could define India's path to becoming a global healthcare leader by 2047. India currently ranks 120 out of 156 countries on the UN Sustainable Development Goals (SDG) Index, reflecting an urgent need to adopt frameworks that move from short-term charity to measurable, long-term impact. In a conversation with ETHealthworld, Amit Bhatia, Founder of Aspire Impact and Aspire Circle, emphasised the growing relevance of ESG in reshaping healthcare outcomes across the country. 'ESG enables us to move from charity to capitalism with conscience . It incentivises healthcare providers to address underserved populations through market-based mechanisms, improving both health outcomes and investment returns,' he said. India's healthcare landscape is marked by deep-rooted inequities, especially in rural and tier 2/3 cities, where critical gaps in infrastructure, affordability, and access remain. According to Bhatia, traditional philanthropy often lacks scale, sustainability, and accountability. ESG frameworks, by contrast, offer structured and quantifiable models backed by 150+ healthcare-specific Key Performance Indicators (KPIs). These KPIs track metrics viz patient safety and care quality, medical waste management, gender equity and workforce inclusion, affordability and last-mile access, digital health adoption and ethical governance and transparency 'Only 25 per cent of Indian companies disclose ESG metrics today. But those that do often enjoy 5 to 20 per cent higher valuation multiples, increased investor trust, and improved brand equity,' Bhatia noted. Unlike one-off donations or government subsidies that risk creating dependency, ESG-driven investments aim to align profitability with purpose. Aspire Impact uses a Dual ESG Ratings & Rankings system that evaluates companies on both risk mitigation and impact potential, helping guide capital towards organisations making a measurable difference—particularly in low-access geographies. Through its evaluation of over 1,000 companies, Aspire has helped develop sector-specific ESG roadmaps tailored to various industries. The healthcare ESG framework, launched in 2022, is designed to support providers operating in underserved regions, where demand for quality, inclusive care is rapidly growing. Bhatia also highlighted how embedding ESG principles into public health initiatives—such as the Ayushman Bharat Digital Health Mission (ABDM)—can significantly enhance transparency, accountability, and scalability. He further called for greater alignment between ESG disclosures and India's regulatory mandates, including the Companies Act and SEBI's ESG reporting requirements. This alignment, he noted, could catalyse widespread adoption of ESG frameworks across both public and private healthcare players. 'The future of healthcare is not just digital or data-driven, it must be value-driven. ESG allows us to quantify our intentions, measure our progress, and attract capital that's both responsible and results-oriented,' Bhatia said. With sustainability and accountability becoming top priorities for investors, ESG adoption in healthcare is no longer optional—it's a strategic imperative. For India to bridge persistent gaps in equity, affordability, and access, ESG provides a clear and actionable pathway to achieving universal healthcare goals while reinforcing national resilience. As India looks ahead to its centenary in 2047, embedding ESG principles into healthcare strategy could become a defining lever—reshaping not just institutions, but also the future of public health and social impact in the country.
